DE3119514C2 - - Google Patents

Info

Publication number
DE3119514C2
DE3119514C2 DE19813119514 DE3119514A DE3119514C2 DE 3119514 C2 DE3119514 C2 DE 3119514C2 DE 19813119514 DE19813119514 DE 19813119514 DE 3119514 A DE3119514 A DE 3119514A DE 3119514 C2 DE3119514 C2 DE 3119514C2
Authority
DE
Germany
Prior art keywords
triacetonamine
acetone
solvent
hydrochloride
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19813119514
Other languages
German (de)
English (en)
Other versions
DE3119514A1 (de
Inventor
Bernarda Castillo Brito
Armando Cuellar Havana City Cu Cuellar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMPRESA CUBANA EXPORTADORA E IMPORTADORA DE PRODUCTOS MEDICOS MEDICUBA HAVANNA/LA HABANA CU
Original Assignee
EMPRESA CUBANA EXPORTADORA E IMPORTADORA DE PRODUCTOS MEDICOS MEDICUBA HAVANNA/LA HABANA CU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMPRESA CUBANA EXPORTADORA E IMPORTADORA DE PRODUCTOS MEDICOS MEDICUBA HAVANNA/LA HABANA CU filed Critical EMPRESA CUBANA EXPORTADORA E IMPORTADORA DE PRODUCTOS MEDICOS MEDICUBA HAVANNA/LA HABANA CU
Priority to DE19813119514 priority Critical patent/DE3119514A1/de
Publication of DE3119514A1 publication Critical patent/DE3119514A1/de
Application granted granted Critical
Publication of DE3119514C2 publication Critical patent/DE3119514C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19813119514 1981-05-15 1981-05-15 Triacetonaminhydrochlorid, verfahren zu seiner herstellung und arzneimittel Granted DE3119514A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19813119514 DE3119514A1 (de) 1981-05-15 1981-05-15 Triacetonaminhydrochlorid, verfahren zu seiner herstellung und arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813119514 DE3119514A1 (de) 1981-05-15 1981-05-15 Triacetonaminhydrochlorid, verfahren zu seiner herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
DE3119514A1 DE3119514A1 (de) 1983-02-24
DE3119514C2 true DE3119514C2 (fr) 1990-03-29

Family

ID=6132475

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813119514 Granted DE3119514A1 (de) 1981-05-15 1981-05-15 Triacetonaminhydrochlorid, verfahren zu seiner herstellung und arzneimittel

Country Status (1)

Country Link
DE (1) DE3119514A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE403478B (sv) * 1973-06-25 1978-08-21 Ciba Geigy Ag Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin
NO742246L (fr) * 1973-06-26 1975-01-20 Sankyo Co

Also Published As

Publication number Publication date
DE3119514A1 (de) 1983-02-24

Similar Documents

Publication Publication Date Title
DE69309065T2 (de) Direkt veresterung von mycophenolsäure
DE69429774T2 (de) Magnesium-omeprazol
DE69229339T2 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
EP0036663B1 (fr) Dérivés de l'acide oxiranne-butyrique, leur préparation et leur utilisation ainsi que médicaments les contenant
EP0003029B1 (fr) Nouveaux dérivés de l'acide 2-oxo-1-pyrrolidine-acétique, procédé pour leur préparation, médicaments les contenant et procédé pour leur préparation
EP0044989B1 (fr) 5,10-Dihydro-11H-dibenzo(b,e)(1,4)diazépin-11-ones substituées en position 5, procédé pour leur préparation et médicaments les contenant
DE69104948T2 (de) Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE2557145C3 (de) Tyrosinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2458908C2 (de) Alkanolaminderivate und sie enthaltende pharmazeutische Zusammensetzungen
DE3119514C2 (fr)
CH621780A5 (fr)
DE3102769A1 (de) "bis-moranolinderivate"
CH639363A5 (de) Bis/nitrosoureido/-polyol-derivate und verfahren zu ihrer herstellung.
DE2557033C2 (de) Acylderivate des 1,2-5,6-Dianhydro-dulcits, Verfahren zu deren Herstellung und diese Verbindungen enthaltende anticarcinogene Mittel
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2028880C3 (de) N-Phenylcarbamoyl-3-(ßphenylisopropyl)sydnonunin, Verfahren zu dessen Herstellung und Arzneimittel
DE2632115C2 (fr)
AT390614B (de) Verfahren zur herstellung von neuen 2-halogen-nicergolinen
DE69500120T2 (de) Verwendung von Dehydroalanin-Derivate zum Schutz der Haut, der Schleimhaut und/oder des Haares gegen oxidativen Stress, diese enthaltende kosmetische oder dermatologische Zusammensetzungen und ähnliche neue Verbindungen
DE1795731A1 (de) Verfahren zur herstellung neuer antibiotisch wirksamer verbindungen
DE3204588C2 (fr)
DE2430510B2 (de) 16,17-Dihydroapovincaminsäureamide, Verfahren zu deren Herstellung und Arzneimittel, welche diese Verbindungen enthalten
DE69612626T2 (de) Hydrat-kristall und verfahren zu seiner herstellung
DE2710807C2 (de) Benzylamino-alkancarboxamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH615925A5 (fr)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3153609

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3153609

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8328 Change in the person/name/address of the agent

Free format text: BLUMBACH, P., DIPL.-ING., 6200 WIESBADEN WESER, W., DIPL.-PHYS. DR.RER.NAT. KRAMER, R., DIPL.-ING.,8000 MUENCHEN ZWIRNER, G., DIPL.-ING. DIPL.-WIRTSCH.-ING., 6200 WIESBADEN HOFFMANN, E., DIPL.-ING., PAT.-ANWAELTE, 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee